Harmony Drug Patent Portfolio
Harmony owns 1 orange book drug protected by 5 US patents Given below is the list of Harmony's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8207197 | Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy] propyl] -piperidine | 07 Mar, 2030 | Active |
| US8486947 | Treatment of Parkinson's disease, obstructive sleep apnea, dementia with Lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3-receptor ligands | 26 Sep, 2029 | Active |
| US8354430 | Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine | 06 Feb, 2026 | Active |
| US7910605 | Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications | 23 Sep, 2022 | Expired |
| US7169928 | Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications | 02 Feb, 2020 | Expired |
Latest Legal Activities on Harmony's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Harmony.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Yr, Small Entity | 15 Jul, 2024 | US8354430 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 21 Dec, 2023 | US8207197 |
|
Electronic Review
Critical
| 08 Aug, 2023 | US8207197 |
|
Email Notification
Critical
| 08 Aug, 2023 | US8207197 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 08 Aug, 2023 | US8207197 |
|
Expire Patent
Critical
| 24 Apr, 2023 | US7910605 |
|
Maintenance Fee Reminder Mailed
Critical
| 07 Nov, 2022 | US7910605 |
|
Patent Term Extension Certificate
Critical
| 06 Oct, 2022 | US8207197 |
|
Withdrawal of Application for PTE
Critical
| 30 Aug, 2022 | US8486947 |
| Notice of Final Determination -Election Required | 11 Jul, 2022 | US8486947 |
| Notice of Final Determination -Election Required | 08 Jul, 2022 | US8207197 |
| Notice of Final Determination -Election Required | 08 Jul, 2022 | US8486947 |
|
FDA Final Eligibility Letter
Critical
| 17 Feb, 2022 | US8207197 |
|
FDA Final Eligibility Letter
Critical
| 17 Feb, 2022 | US8486947 |
| transaction for FDA Determination of Regulatory Review Period | 10 Jun, 2021 | US8207197 |
Harmony's Family Patents
Harmony drugs have patent protection in a total of 32 countries. It's US patent count contributes only to 10.2% of its total global patent coverage. Click
below to unlock the full patent family tree.
Harmony Drug List
Given below is the complete list of Harmony's drugs and the patents protecting them.
1. Wakix
Wakix is protected by 5 patents, out of which 2 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8207197 | Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy] propyl] -piperidine |
07 Mar, 2030
(5 years from now)
| Active |
| US8486947 | Treatment of Parkinson's disease, obstructive sleep apnea, dementia with Lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3-receptor ligands |
26 Sep, 2029
(4 years from now)
| Active |
| US8354430 | Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine |
06 Feb, 2026
(1 year, 15 days from now)
| Active |
| US7910605 | Non-imidazole alkylamines as histamine H3- receptor ligands and their therapeutic applications |
23 Sep, 2022
(2 years ago)
| Expired |
| US7169928 | Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications |
02 Feb, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Wakix's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List